Table 4 Multiple hierarchal linear regression analysis for benefit finding following surgery (n = 1541)
B | SE | ß | p-value | R2 | |
|---|---|---|---|---|---|
STEP 1 Sociodemographic factors | 0.006 | ||||
Age at survey (years) (continuous) | -0.006 | 0.003 | -0.053 | 0.039 | |
Partnership (ref. no) | 0.100 | 0.074 | 0.035 | 0.178 | |
Children(ref. no) | 0.093 | 0.061 | 0.040 | 0.127 | |
STEP 2 Presurgical clinical factors | 0.012 | ||||
Age at survey (years) (continuous) | -0.007 | 0.003 | -0.061 | 0.027 | |
Partnership (ref. no) | 0.104 | 0.074 | 0.036 | 0.163 | |
Children(ref. no) | 0.092 | 0.061 | 0.039 | 0.133 | |
Time since surgery (years)(ref. 0-≤1) | |||||
Preoperative | 0.071 | 0.112 | 0.017 | 0.530 | |
2-≤5 | -0.013 | 0.060 | -0.007 | 0.825 | |
> 5 | -0.008 | 0.064 | -0.004 | 0.903 | |
s primary cancer(ref. no) | -0.130 | 0.090 | -0.038 | 0.141 | |
Family history of PCa(ref. no) | -0.060 | 0.050 | -0.031 | 0.234 | |
RCS Charlson Score (at surgery)(continuous) | 0.106 | 0.045 | 0.064 | 0.019 | |
PSA Lever at diagnosis (ref. ≤4) | |||||
> 4 ≤ 10 | -0.049 | 0.080 | -0.026 | 0.538 | |
> 10 | -0.014 | 0.086 | -0.007 | 0.872 | |
STEP 3 Postsurgical clinical factors | 0.028 | ||||
Age at survey (years) (continuous) | -0.008 | 0.003 | -0.071 | 0.009 | |
Partnership (ref. no) | 0.098 | 0.074 | 0.033 | 0.187 | |
Children(ref. no) | 0.091 | 0.061 | 0.039 | 0.133 | |
Time since surgery (years)(ref. 0-≤1) | |||||
Preoperative | 0.111 | 0.111 | 0.027 | 0.320 | |
2-≤5 | -0.037 | 0.059 | -0.020 | 0.531 | |
> 5 | -0.034 | 0.064 | -0.018 | 0.590 | |
s primary cancer(ref. no) | -0.123 | 0.088 | -0.036 | 0.164 | |
Family history of PCa(ref. no) | -0.050 | 0.050 | -0.023 | 0.365 | |
RCS Charlson Score (at surgery)(continuous) | 0.094 | 0.045 | 0.057 | 0.035 | |
PSA Lever at diagnosis (ref. ≤4) | |||||
> 4 ≤ 10 | -0.067 | 0.079 | -0.036 | 0.400 | |
> 10 | -0.093 | 0.087 | -0.046 | 0.289 | |
Biochemical recurrence(ref. no) | 0.199 | 0.060 | 0.092 | 0.001 | |
Ongoing treatment at survey(ref. no) | 0.217 | 0.085 | 0.070 | 0.011 | |
STEP 4 Psychosocial factors | 0.061 | ||||
Age at survey (years) (continuous) | -0.005 | 0.003 | -0.045 | 0.095 | |
Partnership (ref. no) | 0.084 | 0.073 | 0.029 | 0.250 | |
Children(ref. no) | 0.095 | 0.060 | 0.040 | 0.114 | |
Time since surgery (years)(ref. 0-≤1) | |||||
Preoperative | 0.073 | 0.110 | 0.018 | 0.510 | |
2-≤5 | -0.025 | 0.060 | -0.014 | 0.664 | |
> 5 | -0.027 | 0.063 | -0.015 | 0.658 | |
s primary cancer(ref. no) | -0.079 | 0.087 | -0.023 | 0.364 | |
Family history of PCa(ref. no) | -0.045 | 0.050 | -0.023 | 0.357 | |
RCS Charlson Score (at surgery)(continuous) | 0.095 | 0.044 | 0.057 | 0.032 | |
PSA Lever at diagnosis (ref. ≤4) | |||||
> 4 ≤ 10 | -0.060 | 0.078 | -0.032 | 0.442 | |
> 10 | -0.104 | 0.086 | -0.052 | 0.227 | |
Biochemical recurrence(ref. no) | 0.193 | 0.059 | 0.089 | 0.001 | |
Ongoing treatment at survey(ref. no) | 0.160 | 0.084 | 0.052 | 0.052 | |
Perceived severity of disease(continuous) | 0.113 | 0.025 | 0.123 | < 0.0001 | |
Depressive symptoms (PHQ-2)(ref. negative screening (< 3)) | -0.070 | 0.097 | -0.022 | 0.469 | |
Anxiety symptoms (GAD-2)(ref. negative screening (< 3)) | -0.153 | 0.105 | -0.045 | 0.145 | |
Psychosocial distress (QSC-R10)(ref. low < 15) | 0.011 | 0.004 | 0.103 | 0.005 | |
Need for psychological support(ref. no) | 0.106 | 0.057 | 0.049 | 0.063 | |
Quality of life (QLQ-C30)(continuous) | 0.062 | 0.016 | 0.124 | < 0.0001 |